Aktiveret partiel thromboplastintid (aPTT) skal monitoreres hos patienter med mild til moderat nedsat nyrefunktion (kreatininclearance mellem 31 og 90 ml/ min; se pkt.
In patients with mild or moderate renal impairment (creatinine clearance between 31 and 90 ml/ min; see section 4.4) activated partial thromboplastin time (aPTT) should be monitored.